DDX41 Recognizes RNA/DNA Retroviral Reverse Transcripts and Is Critical for In Vivo Control of Murine Leukemia Virus Infection

por Stavrou, Spyridon, Aguilera, Alexya N., Blouch, Kristin, Ross, Susan R.
Publicado 2018

DDX41 is required for cGAS-STING activation against DNA virus infection

por Singh, Ravi Shankar, Vidhyasagar, Venkatasubramanian, Yang, Shizhuo, Arna, Ananna Bhadra, Yadav, Manisha, Aggarwal, Aanchal, Aguilera, Alexya N., Shinriki, Satoru, Bhanumathy, Kalpana Kalyanasundaram, Pandey, Kannupriya, Xu, Aizhang, Rapin, Noreen, Bosch, Mark, DeCoteau, John, Xiang, Jim, Vizeacoumar, Franco J., Zhou, Yan, Misra, Vikram, Matsui, Hirotaka, Ross, Susan R., Wu, Yuliang
Publicado 2022

APOBEC3A catalyzes mutation and drives carcinogenesis in vivo

por Law, Emily K., Levin-Klein, Rena, Jarvis, Matthew C., Kim, Hyoung, Argyris, Prokopios P., Carpenter, Michael A., Starrett, Gabriel J., Temiz, Nuri A., Larson, Lindsay K., Durfee, Cameron, Burns, Michael B., Vogel, Rachel I., Stavrou, Spyridon, Aguilera, Alexya N., Wagner, Sandra, Largaespada, David A., Starr, Timothy K., Ross, Susan R., Harris, Reuben S.
Publicado 2020